---
title: "CINC.US (CINC.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/CINC.US/news.md"
symbol: "CINC.US"
name: "CINC.US"
parent: "https://longbridge.com/zh-HK/quote/CINC.US.md"
datetime: "2026-03-17T16:25:11.564Z"
locales:
  - [en](https://longbridge.com/en/quote/CINC.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CINC.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CINC.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/CINC.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/CINC.US/news.md)


# CINC.US (CINC.US) — 相關新聞

### [H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036) | DelveInsight | CPIX Stock News](https://longbridge.com/zh-HK/news/277844408.md)
*2026-03-04T14:46:00.000Z*
> The H. pylori infections market is projected to grow at a CAGR of 9.5% from 2026 to 2036, driven by advancements in trea

### [Cinclus Pharma Says FDA Clarifies Pivotal Study](https://longbridge.com/zh-HK/news/276571432.md)
*2026-02-23T07:04:52.000Z*
### [Cinclus Pharma Gets Positive Assessment From FDA](https://longbridge.com/zh-HK/news/275864026.md)
*2026-02-13T07:32:54.000Z*
### [17:31 ET
			
			
				Gastroesophageal Reflux Disease Market in the US to Show Promising Growth at a CAGR of 6% During the Forecast Period (2025-2034) | DelveInsight](https://longbridge.com/zh-HK/news/273432573.md)
*2026-01-22T22:32:04.000Z*
> The gastroesophageal reflux disease (GERD) market in the US is projected to grow at a CAGR of 6% from 2025 to 2034, driv

### [CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat](https://longbridge.com/zh-HK/news/80499914.md)
*2023-02-21T13:03:02.000Z*
> (marketscreener.com) WALTHAM, Mass., Feb. 21, 2023 -- CinCor Pharma, Inc. announced today completion of an End-of-Phase 

### [CINCOR PHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CinCor Pharma, Inc. - CINC](https://longbridge.com/zh-HK/news/78245426.md)
*2023-01-24T16:35:02.000Z*
> (marketscreener.com) Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Fo

### [CINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CinCor Pharma, Inc. Is Fair to Shareholders](https://longbridge.com/zh-HK/news/77186994.md)
*2023-01-09T13:47:40.000Z*
> Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of CinCor Pharma, Inc. (NASDAQ: CINC) t